Abstract
Clinical research on the therapeutic efficacy of psychedelics is currently experiencing a renaissance. Available scientific evidence on their efficacy in various psychiatric conditions, as well as their legally approved use in some countries of the world, show the possibility of their future application in clinical practice also in Germany. The field is facing substantial challenges that have to be addressed, such as defining and setting a suitable clinical frame. This manuscript deals with the historical background of the clinical application of psychedelics, as well as the psycho-phenomenology, modes of action, possible indications and aspects of safety. The current research status in Germany and the organization of professional societies are discussed in a historical and international context and attention is drawn to unresolved critical issues in the field.
| Translated title of the contribution | Psychedelics in Psychiatry - Development and Current State in Germany |
|---|---|
| Original language | German |
| Journal | Fortschritte der Neurologie Psychiatrie |
| Volume | 91 |
| Issue number | 7-8 |
| Pages (from-to) | 311-318 |
| Number of pages | 8 |
| ISSN | 0720-4299 |
| DOIs | |
| Publication status | Published - 04.07.2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
DFG Research Classification Scheme
- 2.23-10 Clinical Psychiatry, Psychotherapy, Child and Adolescent Psychiatry
- 2.22-08 Pharmacy
Fingerprint
Dive into the research topics of 'Psychedelics in Psychiatry - Development and Current State in Germany'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver